Silencing HCV Replication in Its Reservoir

BACKGROUND: HCV infection and its complications are among the leading public health challenges; the emergence of drug-resistant variants are expected to be a major problem. A novel combinatorial small interfering RNA (siRNA) could be a novel triple therapy that could be suitable for genotype 4. Alth...

Descripción completa

Detalles Bibliográficos
Autores principales: Youssef, Samar Samir, Elemeery, Moustafa Nouh, Eldein, Sameh Seif, Ghareeb, Doaa Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Republic of Macedonia 2018
Materias:
Basic Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290455/
https://www.ncbi.nlm.nih.gov/pubmed/30559844
http://dx.doi.org/10.3889/oamjms.2018.372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290455/
https://www.ncbi.nlm.nih.gov/pubmed/30559844
http://dx.doi.org/10.3889/oamjms.2018.372

Ejemplares similares